r.rotation.to⌕ Search stocks, people, sectors
Following this device: dark.
Request a free account

Follow the people · Insider

ML

Mary Kay Ladone

Insider · Director · KMTS

Mary Kay Ladone files insider transactions with the SEC as a director of Kestra Medical Technologies. We hold 1 disclosed purchase or sale filed since 8 March 2019, 1 of them in the last 90 days.

  • Files for 5 companiesKMTS, INGN, BVS, NOVT and 1 more
  • Disclosed buys and sells1 in all, 1 in the last 90 days
  • Last disclosure10 September 2026

Positions held

5 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 4 September 2025 — 9 September 2026Director · Kestra Medical Technologies 3 Form 4 lines · source: SEC Form 4
  • Filed 22 March 2022 — 5 June 2026Director · Inogen 6 Form 4 lines · source: SEC Form 4
  • Filed 15 July 2021 — 3 June 2026Director · Bioventus 20 Form 4 lines · source: SEC Form 4
  • Filed 11 July 2024 — 2 January 2026Director · Novanta 10 Form 4 lines · source: SEC Form 4
  • Filed 6 March 2019 — 13 December 2021SVP, Corp. Dev., Strat. & IR · Hill-Rom Holdings 80 Form 4 lines · source: SEC Form 4

Every transaction

119 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing
119 of 119 shown
9 Sep 202610 Sep 2026SEC Form 41 dwas grantednot a tradeKestra Medical Technologies7,217 sharesdown −5.1%down −3.1%
8 Sep 202610 Sep 2026SEC Form 42 dsold on the open marketKestra Medical Technologies3,908 sharesdown −10.9%down −3.1%
5 Jun 20269 Jun 2026SEC Form 44 dwas grantednot a tradeInogen28,081 sharesdown −17.2%down −16.4%
3 Jun 20264 Jun 2026SEC Form 41 dwas grantednot a tradeBioventusderivative25,146 sharesup +51.8%up +49.2%
2 Jun 20264 Jun 2026SEC Form 42 dexercised options overnot a tradeBioventus32,282 sharesup +60.0%up +49.2%
2 Jun 20264 Jun 2026SEC Form 42 dexercised options overnot a tradeBioventusderivative32,282 sharesup +60.0%up +49.2%
2 Jan 20266 Jan 2026SEC Form 44 dexercised options overnot a tradeNovanta1,325 sharesup +31.9%up +17.5%
2 Jan 20266 Jan 2026SEC Form 44 dexercised options overnot a tradeNovantaderivative1,325 sharesup +31.9%up +17.5%
2 Jan 20266 Jan 2026SEC Form 44 dwas grantednot a tradeNovantaderivative1,799 sharesup +31.9%up +17.5%
2 Jan 20266 Jan 2026SEC Form 44 dexercised options overnot a tradeNovantaderivative1,325 sharesup +31.9%up +17.5%
2 Jan 20266 Jan 2026SEC Form 44 dwas grantednot a tradeNovantaderivative1,799 sharesup +31.9%up +17.5%
2 Jan 20266 Jan 2026SEC Form 44 dexercised options overnot a tradeNovanta1,325 sharesup +31.9%up +17.5%
4 Sep 20258 Sep 2025SEC Form 44 dwas grantednot a tradeKestra Medical Technologies10,909 sharesup +38.4%up +27.9%
11 Jul 202514 Jul 2025SEC Form 43 dexercised options overnot a tradeNovantaderivative572 sharesup +11.3%up +15.7%
11 Jul 202514 Jul 2025SEC Form 43 dexercised options overnot a tradeNovanta572 sharesup +11.3%up +15.7%
3 Jun 20254 Jun 2025SEC Form 41 dwas grantednot a tradeBioventusderivative32,282 sharesup +94.9%up +98.8%
2 Jun 20254 Jun 2025SEC Form 42 dexercised options overnot a tradeBioventusderivative26,493 sharesup +101.6%up +98.8%
2 Jun 20254 Jun 2025SEC Form 42 dexercised options overnot a tradeBioventus26,493 sharesup +101.6%up +98.8%
14 May 202516 May 2025SEC Form 42 dwas grantednot a tradeInogen30,612 sharesdown −9.7%down −12.8%
2 Jan 20256 Jan 2025SEC Form 44 dwas grantednot a tradeNovantaderivative1,325 sharesdown −2.9%down −2.8%
11 Jul 202415 Jul 2024SEC Form 44 dwas grantednot a tradeNovantaderivative572 sharesdown −11.5%down −15.4%
16 Jun 202418 Jun 2024SEC Form 42 dexercised options overnot a tradeBioventusderivative1,814 sharesup +103.4%up +123.0%
16 Jun 202418 Jun 2024SEC Form 42 dexercised options overnot a tradeBioventus1,814 sharesup +103.4%up +123.0%
11 Jun 202413 Jun 2024SEC Form 42 dwas grantednot a tradeBioventusderivative26,493 sharesup +98.8%up +98.5%
7 Jun 202411 Jun 2024SEC Form 44 dexercised options overnot a tradeBioventusderivative30,400 sharesup +105.1%up +98.8%
7 Jun 202411 Jun 2024SEC Form 44 dexercised options overnot a tradeBioventus30,400 sharesup +105.1%up +98.8%
5 Jun 20247 Jun 2024SEC Form 42 dwas grantednot a tradeInogen21,871 sharesdown −35.5%down −38.5%
16 Jun 202320 Jun 2023SEC Form 44 dexercised options overnot a tradeBioventusderivative1,813 sharesup +310.1%up +317.4%
16 Jun 202320 Jun 2023SEC Form 44 dexercised options overnot a tradeBioventus1,813 sharesup +310.1%up +317.4%
7 Jun 20238 Jun 2023SEC Form 41 dwas grantednot a tradeBioventusderivative30,400 sharesup +360.3%up +329.8%
6 Jun 20238 Jun 2023SEC Form 42 dexercised options overnot a tradeBioventusderivative16,648 sharesup +347.6%up +329.8%
6 Jun 20238 Jun 2023SEC Form 42 dexercised options overnot a tradeBioventus16,648 sharesup +347.6%up +329.8%
31 May 20232 Jun 2023SEC Form 42 dwas grantednot a tradeInogen17,094 sharesdown −49.6%down −50.9%
17 Jun 202222 Jun 2022SEC Form 45 dwas grantednot a tradeBioventusderivative16,648 sharesup +42.2%up +51.3%
16 Jun 202222 Jun 2022SEC Form 46 dexercised options overnot a tradeBioventusderivative1,813 sharesup +47.8%up +51.3%
16 Jun 202222 Jun 2022SEC Form 46 dexercised options overnot a tradeBioventus1,813 sharesup +47.8%up +51.3%
8 Jun 202210 Jun 2022SEC Form 42 dwas grantednot a tradeInogen6,849 sharesdown −79.8%down −79.6%
22 Mar 202224 Mar 2022SEC Form 42 dwas grantednot a tradeInogen459 sharesdown −84.1%down −83.6%
13 Dec 202115 Dec 2021SEC Form 42 dreturned to the issuernot a tradeHRCHill-Rom Holdingsderivative4,102 shares——
13 Dec 202115 Dec 2021SEC Form 42 dreturned to the issuernot a tradeHRCHill-Rom Holdingsderivative6,054 shares——
13 Dec 202115 Dec 2021SEC Form 42 dreturned to the issuernot a tradeHRCHill-Rom Holdingsderivative3,947 shares——
13 Dec 202115 Dec 2021SEC Form 42 dreturned to the issuernot a tradeHRCHill-Rom Holdingsderivative4,092 shares——
13 Dec 202115 Dec 2021SEC Form 42 dreturned to the issuernot a tradeHRCHill-Rom Holdingsderivative664 shares——
13 Dec 202115 Dec 2021SEC Form 42 dreturned to the issuernot a tradeHRCHill-Rom Holdingsderivative1,363 shares——
13 Dec 202115 Dec 2021SEC Form 42 dreturned to the issuernot a tradeHRCHill-Rom Holdingsderivative6,708 shares——
13 Dec 202115 Dec 2021SEC Form 42 dreturned to the issuernot a tradeHRCHill-Rom Holdings2,284 shares——
12 Nov 202116 Nov 2021SEC Form 44 dexercised options overnot a tradeHRCHill-Rom Holdingsderivative700 shares——
12 Nov 202116 Nov 2021SEC Form 44 dexercised options overnot a tradeHRCHill-Rom Holdings700 shares——
12 Nov 202116 Nov 2021SEC Form 44 dhad shares withheld for taxnot a tradeHRCHill-Rom Holdings253 shares——
11 Nov 202112 Nov 2021SEC Form 41 dexercised options overnot a tradeHRCHill-Rom Holdingsderivative2,018 shares——
11 Nov 202112 Nov 2021SEC Form 41 dexercised options overnot a tradeHRCHill-Rom Holdings2,018 shares——
11 Nov 202112 Nov 2021SEC Form 41 dsold on the open marketHRCHill-Rom Holdings2,018 shares——
10 Nov 202112 Nov 2021SEC Form 42 dwas grantednot a tradeHRCHill-Rom Holdingsderivative6,708 shares——
8 Nov 202110 Nov 2021SEC Form 42 dexercised options overnot a tradeHRCHill-Rom Holdingsderivative872 shares——
8 Nov 202110 Nov 2021SEC Form 42 dexercised options overnot a tradeHRCHill-Rom Holdingsderivative2,051 shares——
8 Nov 202110 Nov 2021SEC Form 42 dexercised options overnot a tradeHRCHill-Rom Holdingsderivative1,937 shares——
8 Nov 202110 Nov 2021SEC Form 42 dexercised options overnot a tradeHRCHill-Rom Holdingsderivative662 shares——
8 Nov 202110 Nov 2021SEC Form 42 dexercised options overnot a tradeHRCHill-Rom Holdings872 shares——
8 Nov 202110 Nov 2021SEC Form 42 dsold on the open marketHRCHill-Rom Holdings872 shares——
8 Nov 202110 Nov 2021SEC Form 42 dexercised options overnot a tradeHRCHill-Rom Holdings2,051 shares——
8 Nov 202110 Nov 2021SEC Form 42 dsold on the open marketHRCHill-Rom Holdings2,051 shares——
8 Nov 202110 Nov 2021SEC Form 42 dexercised options overnot a tradeHRCHill-Rom Holdings1,937 shares——
8 Nov 202110 Nov 2021SEC Form 42 dhad shares withheld for taxnot a tradeHRCHill-Rom Holdings568 shares——
8 Nov 202110 Nov 2021SEC Form 42 dexercised options overnot a tradeHRCHill-Rom Holdings662 shares——
8 Nov 202110 Nov 2021SEC Form 42 dhad shares withheld for taxnot a tradeHRCHill-Rom Holdings194 shares——
28 Jul 202130 Jul 2021SEC Form 42 dsold on the open marketHRCHill-Rom Holdings3,000 shares——
28 Jul 202130 Jul 2021SEC Form 42 dsold on the open marketHRCHill-Rom Holdings2,698 shares——
28 Jul 202130 Jul 2021SEC Form 42 dexercised options overnot a tradeHRCHill-Rom Holdings1,307 shares——
28 Jul 202130 Jul 2021SEC Form 42 dsold on the open marketHRCHill-Rom Holdings1,307 shares——
28 Jul 202130 Jul 2021SEC Form 42 dexercised options overnot a tradeHRCHill-Rom Holdings2,051 shares——
28 Jul 202130 Jul 2021SEC Form 42 dsold on the open marketHRCHill-Rom Holdings2,051 shares——
28 Jul 202130 Jul 2021SEC Form 42 dexercised options overnot a tradeHRCHill-Rom Holdingsderivative1,307 shares——
28 Jul 202130 Jul 2021SEC Form 42 dexercised options overnot a tradeHRCHill-Rom Holdingsderivative2,051 shares——
23 Jul 202127 Jul 2021SEC Form 44 dsold on the open marketHRCHill-Rom Holdings6,000 shares——
23 Jul 202127 Jul 2021SEC Form 44 dexercised options overnot a tradeHRCHill-Rom Holdings1,042 shares——
23 Jul 202127 Jul 2021SEC Form 44 dsold on the open marketHRCHill-Rom Holdings1,042 shares——
23 Jul 202127 Jul 2021SEC Form 44 dexercised options overnot a tradeHRCHill-Rom Holdings1,307 shares——
23 Jul 202127 Jul 2021SEC Form 44 dsold on the open marketHRCHill-Rom Holdings1,307 shares——
23 Jul 202127 Jul 2021SEC Form 44 dexercised options overnot a tradeHRCHill-Rom Holdingsderivative1,042 shares——
23 Jul 202127 Jul 2021SEC Form 44 dexercised options overnot a tradeHRCHill-Rom Holdingsderivative1,307 shares——
15 Jul 202119 Jul 2021SEC Form 44 dwas grantednot a tradeBioventusderivative5,440 sharesdown −19.6%down −20.2%
11 Nov 202013 Nov 2020SEC Form 42 dwas grantednot a tradeHRCHill-Rom Holdingsderivative2,046 shares——
11 Nov 202013 Nov 2020SEC Form 42 dwas grantednot a tradeHRCHill-Rom Holdingsderivative8,072 shares——
9 Nov 202010 Nov 2020SEC Form 41 dexercised options overnot a tradeHRCHill-Rom Holdingsderivative991 shares——
9 Nov 202010 Nov 2020SEC Form 41 dexercised options overnot a tradeHRCHill-Rom Holdingsderivative1,919 shares——
9 Nov 202010 Nov 2020SEC Form 41 dexercised options overnot a tradeHRCHill-Rom Holdingsderivative676 shares——
9 Nov 202010 Nov 2020SEC Form 41 dexercised options overnot a tradeHRCHill-Rom Holdings991 shares——
9 Nov 202010 Nov 2020SEC Form 41 dhad shares withheld for taxnot a tradeHRCHill-Rom Holdings291 shares——
9 Nov 202010 Nov 2020SEC Form 41 dexercised options overnot a tradeHRCHill-Rom Holdings1,919 shares——
9 Nov 202010 Nov 2020SEC Form 41 dhad shares withheld for taxnot a tradeHRCHill-Rom Holdings563 shares——
9 Nov 202010 Nov 2020SEC Form 41 dexercised options overnot a tradeHRCHill-Rom Holdings676 shares——
9 Nov 202010 Nov 2020SEC Form 41 dhad shares withheld for taxnot a tradeHRCHill-Rom Holdings199 shares——
3 Nov 20205 Nov 2020SEC Form 42 dexercised options overnot a tradeHRCHill-Rom Holdingsderivative1,418 shares——
3 Nov 20205 Nov 2020SEC Form 42 dexercised options overnot a tradeHRCHill-Rom Holdings1,418 shares——
3 Nov 20205 Nov 2020SEC Form 42 dhad shares withheld for taxnot a tradeHRCHill-Rom Holdings416 shares——
30 Jun 20202 Jul 2020SEC Form 42 dsold on the open marketHRCHill-Rom Holdings2,278 shares——
26 Jun 202029 Jun 2020SEC Form 43 dexercised options overnot a tradeHRCHill-Rom Holdingsderivative3,125 shares——
26 Jun 202029 Jun 2020SEC Form 43 dexercised options overnot a tradeHRCHill-Rom Holdings3,125 shares——
26 Jun 202029 Jun 2020SEC Form 43 dsold on the open marketHRCHill-Rom Holdings3,125 shares——
6 Mar 20209 Mar 2020SEC Form 43 dexercised options overnot a tradeHRCHill-Rom Holdingsderivative1,692 shares——
6 Mar 20209 Mar 2020SEC Form 43 dexercised options overnot a tradeHRCHill-Rom Holdings1,692 shares——
6 Mar 20209 Mar 2020SEC Form 43 dhad shares withheld for taxnot a tradeHRCHill-Rom Holdings519 shares——
15 Nov 201918 Nov 2019SEC Form 43 dexercised options overnot a tradeHRCHill-Rom Holdingsderivative1,185 shares——
15 Nov 201918 Nov 2019SEC Form 43 dexercised options overnot a tradeHRCHill-Rom Holdings1,185 shares——
15 Nov 201918 Nov 2019SEC Form 43 dhad shares withheld for taxnot a tradeHRCHill-Rom Holdings409 shares——
8 Nov 201912 Nov 2019SEC Form 44 dexercised options overnot a tradeHRCHill-Rom Holdingsderivative1,960 shares——
8 Nov 201912 Nov 2019SEC Form 44 dexercised options overnot a tradeHRCHill-Rom Holdings1,960 shares——
8 Nov 201912 Nov 2019SEC Form 44 dhad shares withheld for taxnot a tradeHRCHill-Rom Holdings575 shares——
6 Nov 20197 Nov 2019SEC Form 41 dwas grantednot a tradeHRCHill-Rom Holdingsderivative1,974 shares——
6 Nov 20197 Nov 2019SEC Form 41 dwas grantednot a tradeHRCHill-Rom Holdingsderivative8,204 shares——
5 Nov 20197 Nov 2019SEC Form 42 dexercised options overnot a tradeHRCHill-Rom Holdingsderivative3,539 shares——
5 Nov 20197 Nov 2019SEC Form 42 dexercised options overnot a tradeHRCHill-Rom Holdings3,539 shares——
5 Nov 20197 Nov 2019SEC Form 42 dhad shares withheld for taxnot a tradeHRCHill-Rom Holdings1,037 shares——
22 Jul 201924 Jul 2019SEC Form 42 dexercised options overnot a tradeHRCHill-Rom Holdingsderivative1,647 shares——
22 Jul 201924 Jul 2019SEC Form 42 dexercised options overnot a tradeHRCHill-Rom Holdings1,647 shares——
22 Jul 201924 Jul 2019SEC Form 42 dhad shares withheld for taxnot a tradeHRCHill-Rom Holdings483 shares——
6 Mar 20198 Mar 2019SEC Form 42 dexercised options overnot a tradeHRCHill-Rom Holdingsderivative1,677 shares——
6 Mar 20198 Mar 2019SEC Form 42 dexercised options overnot a tradeHRCHill-Rom Holdings1,677 shares——
6 Mar 20198 Mar 2019SEC Form 42 dhad shares withheld for taxnot a tradeHRCHill-Rom Holdings514 shares——

Both percentages are the stock’s move, not Mary Kay Ladone’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 11 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 39 of the 119 rows shown carry a percentage; the rest are dashes with the reason on the row.

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.

Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.